
-
Alonso's Real Madrid start La Liga with fresh energy
-
Liverpool splash out to secure status as Premier League's top dogs
-
Hong Kong court postpones closing arguments in Jimmy Lai trial
-
Top Japanese fighter retires to support comatose boxer brother
-
Boars, Butterflies or Bees? Public to name Papua New Guinea's NRL team
-
Defending champions Sinner, Sabalenka reach Cincinnati quarters
-
Bolivia presidential hopefuls make last push for votes
-
Trump orders space regulations eased in win for Musk
-
Trump warns of make-or-break chance with Putin as pressure mounts
-
From Snoop Dogg to Tom Brady, stars flock to English second-tier clubs
-
Inside Trump's 'Alligator Alcatraz': detainees allege abuse in a legal black hole
-
Scientists find surprising sex reversal in Australian birds
-
Taylor Swift sets October release for new album
-
Sinner, Sabalenka sail into Cincinnati quarter-finals
-
Oh carp: UK's Lammy on the hook after fishing with Vance without licence
-
Sinner shrugs off rain to dispatch Mannarino in Cincinnati
-
Tainted fentanyl blamed for 87 hospital deaths in Argentina
-
Eyeing robotaxis, Tesla hiring New York test car operator
-
NBA approves $6.1bn sale of Boston Celtics
-
PSG beat Tottenham on penalties to win UEFA Super Cup after late comeback
-
Cowboys owner Jones says experimental drug saved him after cancer diagnosis
-
Striking Boeing defense workers turn to US Congress
-
PSG beat Tottenham on penalties to win UEFA Super Cup
-
Hong Kong court to hear closing arguments in mogul Jimmy Lai's trial
-
US singer Billy Joel to sell off motorcycles due to health condition
-
Barcelona's Ter Stegen validated as long-term injury by La Liga
-
Storm makes landfall in China after raking Taiwan as typhoon
-
Colombia buries assassinated presidential candidate
-
Zverev finishes overnight job at Cincinnati Open
-
Bukele critics face long exile from El Salvador homeland
-
McIlroy 'shot down' suggestion of Ryder Cup playing captain role
-
'Water lettuce' chokes tourism, fishing at El Salvador lake
-
Peru's president signs military crimes amnesty bill into law
-
At least 26 migrants dead in two shipwrecks off Italy
-
Root says Warner jibe 'all part of the fun' heading into Ashes
-
Plastic pollution treaty talks in disarray
-
Trump eyes three-way meeting with Putin, Zelensky
-
'Viable' chance for Ukraine ceasefire thanks to Trump: UK PM
-
Vance visits US troops during UK trip
-
Premier League has no say on delay over Man City charges, says chief exec
-
Trump names Stallone, Strait among Kennedy Center honorees
-
Israeli military says approved plan for new Gaza offensive
-
Europeans urge Trump to push for Ukraine ceasefire in Putin summit
-
Stocks extend gains on US rate-cut bets
-
Venus Williams receives wild card for US Open singles
-
Massive fire burns on mountain near western Canada city
-
Plastic pollution plague blights Asia
-
Typhoon Podul pummels Taiwan, heads towards China
-
Russia in major Ukraine advance as Europe braces for Trump-Putin meet
-
Stock markets extend gains on growing US rate cut hopes

FriskaAi and Dexcom Enter CGM Data Integration Agreement
ARLINGTON, VA / ACCESS Newswire / August 13, 2025 / FriskaAi announced today an agreement with DexCom, Inc., the global leader in glucose biosensing, to integrate data from Dexcom G7 and Dexcom G6 Continuous Glucose Monitoring (CGM) Systems into the FriskaAi platform. Under the agreement, data from Dexcom CGMs will be integrated with Friska Ai, the company's groundbreaking AI-powered healthcare platform supporting physicians and patients with actionable personalized care management programs.
FriskaAi is a physician-directed health and wellness platform that supports the management of diabetes and other chronic diseases by helping providers take an evidence-based approach to preventive care. The EHR-agnostic FriskaAi platform leverages advanced AI and mobile technology to generate personalized health insights and recommendations, empowering patients to take control of their health journey in partnership with their clinical team.
"Impacting more than 38 million Americans, diabetes has emerged as a major public health problem, and its effective management has become a foundational element of preventive medicine," says Shaji Nair, CEO of FriskaAi. "Dexcom's pioneering CGMs are vital tools not only for diabetes management but also for informing broader care decisions. FriskaAi is excited about the potential this integration with Dexcom presents to the physicians relying on our platform for chronic disease management and the patients seeking greater control over their health and wellness."
Dexcom CGMs use a small, wearable sensor to continuously measure and send glucose levels wirelessly to a smart device or receiver in real-time, without the need for fingerpricks. Dexcom CGMs also offer a suite of customizable alerts that can warn of high or low glucose levels and send predictive alerts to help users spend more time in range.
The FriskaAi mobile app securely integrates with Dexcom CGMs and other smart devices, as well as health apps, for analysis by the powerful HIPAA-compliant FriskaAi platform. That data, along with other clinical data and studies, is continuously monitored by sophisticated AI-powered algorithms that alert the patient when action is recommended and generate actionable reports for use by the clinician at the point of care to inform care decisions.
Aggregated health data is also analyzed within the FriskaAI platform to help physicians identify trends and risks within their patient populations, enabling more proactive and preventive care strategies.
About FriskaAi
FriskaAi is a powerful AI-enabled EHR-agnostic platform that helps physicians and other providers take an evidence-based approach to preventive care. The physician-initiated platform leverages advanced AI- and mobile technology to provide patients with personalized health insights and recommendations, empowering them to take control of their health journey in partnership with their clinical team. This aggregated health data, including information from patients' glucometers, other smart devices, and health apps, is continuously analyzed by advanced evidence-based algorithms that alert the patient when action is needed and provide clinicians with actionable reports to inform care decisions. FriskaAi also supports population health strategies by analyzing aggregated health data to identify trends and risks within a defined patient population. For more information, visit www.friska.ai.
Media Contact:
Michele Nachum
NPC Creative Services
[email protected]
SOURCE: FriskaAi
View the original press release on ACCESS Newswire
M.Fischer--AMWN